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immune function; anti-inflammatory; chronic obstructive lung disease; physical activity CHRONIC OBSTRUCTIVE PULMONARY disease (COPD) is a leading cause of death worldwide with a predicted increase in prevalence and mortality (37) . Airway inflammation plays a central role in the pathophysiology of COPD (12, 23) . It is also recognized that the inflammatory response extends beyond the lungs as many patients have chronic, low-grade systemic inflammation that has been linked to a number of secondary comorbidities (11, 17, 32, 38) . There is growing interest in measuring airway and systemic biomarkers to understand and directly monitor these inflammatory processes. Several biomarkers [i.e., interleukin (IL)-6, IL-8, and tumor necrosis factor-␣ (TNF-␣)] are associated with disease severity and exacerbations (2, 22, 65) while others are inflammatory cell chemoattractants (IL-8; Refs. 4, 52) . Chemokine (C-C motif) ligand 5 (CCL5) is associated with leukocyte recruitment and has been implicated in the pathogenesis of COPD (13) . Previous literature (61, 62) has shown that exercise is associated with a transient leukocytosis in patients with COPD; however, the mechanisms by which this occurs are not well characterized. The role of CCL5 in exercise-induced leukocytosis in COPD patients has yet to be clarified. Anti-inflammatory cytokines (i.e., IL-10) balance inflammation by decreasing T-helper lymphocyte function and inhibiting production of proinflammatory cytokines such as IL-1, IL-6, and TNF-␣ (24) . However, in patients with COPD there remains a paucity of data and insufficient understanding of how these biomarkers respond to different stressors such as exercise.
Strenuous exercise increases systemic proinflammatory cytokines in healthy individuals (42) . This is balanced by a similar release of cytokine inhibitors and anti-inflammatory cytokines that restrict the magnitude and duration of the inflammatory response (41, 42, 44, 45) . Unlike healthy individuals, COPD is a chronic inflammatory condition and it is possible that an acute bout of exercise may exaggerate the proinflammatory response or attenuate the anti-inflammatory reaction. Understanding the airway and systemic inflammatory responses may be important for improving responses to treatments and for slowing disease progression. To date, a few preliminary studies (49, 61, 62) have reported that the systemic inflammatory response is intensified following acute strenuous exercise in individuals with COPD. However, no study has investigated the effect of exercise on airway inflammation, the time course of the airway inflammatory response, or the interactions between the airway and systemic inflammatory responses. Therefore, the aim of this study was to determine the effect of an acute bout of exercise on airway and systemic inflammation in steroid-naïve patients with established, smokingrelated COPD. We hypothesized that there would be an increase in markers of airway and systemic inflammation induced by an acute bout of incremental exercise in patients with COPD and that the airway inflammatory response would persist longer than the systemic inflammation.
METHODS

Participants and Research Design
Twenty steroid-naïve patients (15 males: 5 females) with diagnosed COPD [forced expired volume in 1 s (FEV1)/forced vital capacity (FVC) Ͻ0.7, FEV 1 Ͻ80% of predicted value, and a Ͼ10 pack year smoking history], who were Ͼ40 yr of age were recruited for the study from pulmonary clinics. Patients were excluded if they had a history of asthma or allergic rhinitis, required domiciliary oxygen, had an acute exacerbation of COPD within 8 wk of study entry, had a history of any other respiratory disease or inflammatory conditions, were currently exercise training (i.e., Ն3 sessions per wk of Ն30 min per session), or had cardiovascular contraindications to exercise.
This study utilized a prospective, within-subject design. The subjects acted as their own controls. Participants attended our laboratory on three separate occasions. During the initial visit, baseline venous blood samples and induced sputum were collected. Forty-eight hours later subjects performed an incremental exercise test to symptom limitation. Immediately postexercise, a venous blood sample was collected. Induced sputum and another venous blood sample were collected at 2 and 24 h postexercise. Written informed consent was obtained from all participants before the they enrolled in the study. All procedures and the consent form were submitted to, and approved by, the University of Calgary Research Ethics Board.
Procedures
Pulmonary function testing. To confirm the severity of disease and to determine lung volumes, routine spirometry, single-breath diffusion capacity for carbon monoxide (D LCO) and constant-volume body plethysmograph (6200 Autobox; SensorMedics, Yorba Linda, CA) were performed according to American Thoracic Society (ATS) criteria (33, 39, 64) . Established reference equations were used to determine predicted values for spirometry (27) , lung volumes (10), and diffusing capacity (9) .
Incremental exercise test. Subjects performed an incremental exercise test on an electrically braked cycle ergometer (Ergoline 800S; SensorMedics), and expired gases were collected to document peak oxygen consumption (V O2peak) using a metabolic measurement system (Sensormedics Vmax 29C; SensorMedics). The test protocol was performed according to ATS recommendations (1). More specifically, after stable resting metabolic values were achieved, subjects cycled unloaded for 2 min before the load was increased by 5-15 W/min until symptom limitation. During each test, oxyhemoglobin saturation and heart rate were monitored continuously using forehead oximetry (Nellcor N6000; Tyco Healthcare, Louisville, KY) and a 12-lead ECG (CardioSoft; GE Healthcare, Waukesha, WI), respectively. Every 2 min, blood pressure was measured by manual sphygmomanometer and ratings of exertional symptoms (dyspnea and leg discomfort) were also assessed using the modified Borg scale (scale 0 -10; Ref. 6). A maximal effort in the incremental test was defined as the achievement of ventilatory limitation (defined as a ventilatory reserve of Ͻ11 L or a V Emax/MVV of Ͼ0.85) and/or a maximal heart rate of 90% of predicted (1) . V O2peak was considered the highest 30-s V O2 reading obtained during the test. To assess changes in end-expiratory lung volumes, subjects performed a minimum of two inspiratory capacity (IC) maneuvers at rest and every 2 min during exercise. This technique assumes that total lung capacity (TLC) does not change with exercise (55, 66) such that end-expiratory lung volume ϭ TLC Ϫ IC and has previously been shown to be reliable for measuring endexpiratory lung volumes during exercise in individuals with COPD (15, 66) . To ensure IC maneuvers were performed accurately during exercise, tidal breathing was continuously displayed on the monitor of the metabolic measurement system. At the end of a normal expiration, the patient was asked to breathe in without warning and to give an additional effort on top of a maximal inspiration (66) .
Sputum induction and processing. To assess neutrophils and cell count, differential sputum induction was performed using escalating doses of hypertonic saline as per standardized guidelines (16) . In brief, before nebulized saline administration, spirometry, pre-and postbronchodilator, was performed according to ATS criteria (39) . Following baseline spirometry, 9 ml of 0.9% sterile saline were placed into the well of the Universal III ultrasonic nebulizer (Flaem Nuova, Desenzano del Garda Brescia, Italy). The subject inhaled the nebulized mist for 7 min at tidal volume. At the end of 7 min, the subject was instructed to blow their nose, rinse their mouth with water, and then cough and expectorate sputum into a specimen container. Spirometry was repeated to ensure that the baseline FEV1 was within Ͻ10% of baseline. These steps were repeated two more times with 9 ml of 4% sterile saline. After induction, samples were placed on ice and processed for differential cell counts using dithiothreitol (DTT) within 2 h of collection (47) . In brief, mucus plugs were selected and contaminating saliva was removed. The plugs were weighed, and 0.1% DTT was added at four times the sample weight. Samples were vortexed for 15 s and rocked for 15 min at room temperature. An equal volume of PBS was added to the sample bringing the final DTT concentration to 0.05%, after which the samples were mixed and centrifuged at 290 g for 5 min. After centrifugation, the supernatant was removed, aliquoted, and stored at Ϫ80°°C for subsequent quantification of cytokines. Following removal of the supernatant, the cell pellet was resuspended in 1 ml PBS to perform cell counts. Total cell counts were obtained manually using a Bright-line neubuer hemacytometer (Hausser Scientific, Horsham, PA), and the viability of each sample was assessed using the trypan blue exclusion method (54) . The cells were diluted in PBS to 1 ϫ 10 6 /ml and cytospin slides were prepared before being stained with congo red for sputum cell counts. Samples were considered adequate for analysis if there was Ͻ20% squamous cell contamination. Total cell counts were calculated in the following manner: 1) the extracted sputum plugs were weighed; 2) after the DTT and PBS solutions were added, the sample was reweighed to give the final weight; 3) after the slides were prepared, nonsquamous cells were counted, and the total number of cells was divided by the number of triple gridded squares counted (usually 4) and multiplied by 2 (dilution factor for counting), yielding the number of cells (ϫ10 4 ); 4) the number of cells was divided by 100 to give the number of cells per milliliter of suspension (ϫ10 6 ); 5) the number of cells per milliliters of suspension was multiplied by the final weight of the suspension to yield the total number of cells (ϫ10 6 ); and 6) the total number of cells was then divided by the original weight of the extracted sputum to provide the total cells per gram of sputum (ϫ10 6 ). Blood collection and processing. Venous blood samples were taken at the antecubital fossa and collected in appropriate vacucontainers. Blood samples were centrifuged, and the serum was stored at Ϫ80°C for measurement of specific inflammatory biomarkers. Direct assessment of systemic inflammation included a differential cell count (Beckman Coulter LH755; Beckman Coulter, Mississauga, ON, Canada) and CD4 ϩ and CD8 ϩ T lymphocytes. Specifically for the T-lymphocyte measurement, CD3-FITC, CD4-PE, CD8-ECD, and CD45-PC5 antibodies were added to peripheral blood using the automated pipetting system, the PrepPlus2 (Beckman Coulter, Miami, FL). After a 15-min incubation period, erythrocytes were lysed with the TQ-Prep system (Beckman Coulter). Flow Count Fluorospheres (Beckman Coulter) were added using the PrepPlus2 to each tube and were used to calculate absolute CD4 and CD8 counts as per manufacturer's recommendations. Fifty thousand cells were counted, and percent values were calculated. Relative CD4 and CD8 values were determined from a lymphocyte gate on a forward scatter vs. light side scatter histogram after being CD45 gated. Absolute CD4 and CD8 values were derived from a CD3 gate.
Measurement of airway and systemic inflammation. Inflammatory cytokines were measured by a Luminex 200 apparatus (Applied Cytometry Systems) using a multiplex human kit from Millipore (Billerica, MA) according to manufacturer's instructions. Calibration was performed weekly with Luminex/Bioplex Calibration beads (BioRad; cat no. 171-203060). The beads were distributed into each well and washed once. Generation of the standard curves was performed using lyophilized recombinant protein standards supplied with the Millipore kit. These were reconstituted with 250 ul of ddH2O and assayed using a suitable matrix solution. For the standard curve of the sputum samples, the same batch of PBS used to dilute the sputum was used as the matrix solution for the standard curve. All standard curves were five-parameter logistic regression. Duplicate testing of identical assay samples was performed. 11.5) . The samples and the standards were then added to the beads and incubated overnight at 4°C with agitation. After the incubation, the beads were washed three times with wash buffer and incubated with the detection antibodies for 1 h, at room temperature with agitation. Then, the beads were washed again three times and incubated for 30-min at room temperature with phycoerythrin. Finally, the beads were washed three times and resuspended in 75 l of shear fluid. Then, 50 ul of beads (a minimum of 50 events per beads set) were captured by the Luminex 200 apparatus. Data were analyzed with the StarStation V.2.3 software. Upper and lower limits for the cytokine analysis were 1.6 and 10,000 pg/ml, respectively. C-reactive protein (CRP) was measured with the high sensitivity CRP (hsCRP) ELISA (Siemens BN Nephelometer, Siemens Healthcare Diagnostics, Tarrytown, NY) utilizing the CardioPhase high sensitivity CRP reagent.
Statistical Analyses
Descriptive statistics utilized means Ϯ SD for parametric data while median and IQR were used for nonparametric data. Repeatedmeasures ANOVA was performed on parametric data, and the Friedman test on nonparametric data, to evaluate the difference between airway and systemic inflammation across different time periods. If a significant effect was detected, the Tukey's honestly significant difference test was utilized for parametric data and the post hoc analysis on the Friedman test results for nonparametric data. The alpha-level was set a priori at 0.05. To ascertain whether there were associations between the change in sputum cells/cytokines (baseline to 24 h postexercise) and the change in blood eosinophils and serum cytokines, Spearman rank correlations were performed post hoc. The Bonferroni correction was used to adjust the P value for multiple comparisons.
RESULTS
Study Subjects
Baseline subject characteristics are listed in Table 1 . There was a moderate degree of airflow obstruction (mean FEV 1 / FVC 54.5%, mean FEV 1 66% predicted) and evidence of gas-trapping (mean residual volume 135% predicted). TLC and functional residual capacity were within normal limits. Diffusion capacity was not reduced (mean D LCO 91% predicted). Half of the subjects were not using any respiratory medications. There were no significant differences in baseline characteristics or baseline inflammatory markers (in blood and sputum) between those subjects using respiratory medications and those not taking any.
Incremental Exercise Test to Symptom Limitation
Results from the incremental exercise test are presented in Table 2 . All subjects completed the graded exercise test with no adverse events. Subject effort was considered maximal in 16 subjects (80%); of these, thirteen subjects were ventilatory limited. Dynamic hyperinflation, defined by a reduction in IC Ն300 ml, was found in 13 subjects (65%). The majority of subjects stopped exercise due to leg discomfort. Table 3 summarizes the sputum cell results. There was a significant increase in the number of sputum eosinophils (cells/ gram) 24 h postexercise, compared with baseline and immediately postexercise (P ϭ 0.012). No significant difference was found with the percent sputum eosinophils. At baseline, sputum neutrophils were elevated consistent with COPD. Following exercise, no significant changes were found in sputum neutrophils, macrophages, or total cell counts. There was a reduction in IL-6 24 h following exercise compared with baseline (P ϭ 0.01). IL-8 and CCL5 were persistently decreased after exercise (P ϭ 0.0098 and P ϭ 0.0012, respectively), while there was no significant change in IL-10 ( Fig. 1) . Table 4 summarizes the systemic inflammatory results. There was a statistically significant increase in hemoglobin, hematocrit, platelets, total white blood cell count, and lymphocytes immediately after exercise compared with all other time points (P Ͻ 0.0001). Monocytes were also increased (P ϭ 0.011). Neutrophils were increased immediately and 2 h postexercise (P ϭ 0.021), while eosinophils were decreased 2 h after exercise (P ϭ 0.0014) with a return to baseline 24 h later. CD4 ϩ T lymphocytes were decreased 2 h after exercise (P ϭ 0.031), while CD8 ϩ T lymphocytes increased immediately postexercise (P Ͻ 0.001) with a return to baseline by 24 h. The CD4 ϩ -to-CD8 ϩ ratio decreased immediately following exercise (P Ͻ 0.0001). There was no change in hsCRP at any time point. CCL5 was reduced immediately following and 2 h postexercise (P Ͻ 0.0001) with a return to baseline 24 h later. There were no significant changes in the other measured serum cytokines.
Changes in Airway Inflammation with Exercise
Changes in Systemic Inflammation with Exercise
Correlation of Sputum and Blood Markers
We found no significant correlation between the change (baseline to 24 h postexercise) in the number of sputum eosinophils or sputum CCL5 level and the corresponding change in blood eosinophils, serum CCL5, or serum IL-6, IL-8, or IL-10. There was a trend toward a correlation between the change in the number of sputum eosinophils and sputum CCL5 level (r ϭ Ϫ0.57; P ϭ 0.04); however, when corrected for multiple comparisons, the results did not achieve statistical significance.
DISCUSSION
This is the first study to investigate airway inflammatory and anti-inflammatory responses to an acute bout of incremental exercise in patients with COPD. The primary novel findings of this study are that an acute bout of incremental exercise resulted in the following: 1) an increase in the number of sputum eosinophils 24 h after exercise; 2) a reduction of proinflammatory sputum cytokines (IL-6, IL-8, and CCL5); 3) no change in serum or sputum levels of IL-10; and 4) a reduction in serum CCL5 following exercise with a return to baseline 24 h later. Another unique feature of this study was that all subjects were steroid-naïve; therefore, there were no confounding effects of corticosteroids (inhaled or systemic) on the measured inflammatory responses.
Twenty-four hours following an acute bout of incremental exercise, the number of sputum eosinophils was increased in subjects with COPD, with no significant changes in other inflammatory cells. COPD is commonly associated with neutrophilic airway inflammation (18) . However, sputum eosinophilia has been found in up to 40% of stable COPD patients (7, 17, 18, 29, 31, 48, 50) . Recruitment of eosinophils into the airways of our subjects was mirrored by a decrease in blood eosinophils, suggesting sequestration of circulating esoinophils into the airways and relatively rapid transition through the airway wall into the airway lumen within 24 h postexercise. The changes in blood eosinophils paralleled the changes in serum CCL5 after incremental exercise. Influx of eosinophils into the airway is thought, in part, due to release of eosinophilattracting/activating cytokines and chemokines, including CCL5 (20, 26, 51) . Gauvreau et al. (20) found that several cytokines, including CCL5, were responsible for activation and chemotaxis of eosinophils following allergen inhalation challenge and participated in the acute allergen-induced airway eosinophilia observed during the 24 h postchallenge (20) . COPD is associated with increased expression of CCL5 in the bronchial mucosa (13) . Therefore, it is reasonable to suggest that the relative systemic increase in CCL5 and eosinophils following incremental exercise may have promoted recruitment of eosinophils into the airways. During COPD exacerbations, the concentrations of sputum IL-8 and CCL5 have been found to increase compared with stable COPD patients (18) . However, we found a reduction in sputum IL-8 and CCL5 after incremental exercise, suggesting a limited role of these cytokines in mediating airway eosinophil recruitment. What stimulates the recruitment of eosinophils remains unclear. It is possible that an acute bout of incremental exercise results in a systemic stress response in steroid-naïve COPD patients through local respiratory mechanisms including dynamic hyperinflation or persistent expiratory flow limitation.
Sputum analysis did not reveal any significant changes in other cell counts, including neutrophils, after incremental exercise. This is different than sputum changes found during COPD exacerbations, suggesting that the inflammatory stimulus generated by an acute bout of incremental exercise is different. This is not surprising as the vast majority of COPD exacerbations are related to viral and bacterial infections (43) . It is possible that the acute bout of incremental exercise did not significantly activate alveolar macrophages, resulting in the lack of an increase in proinflammatory cytokines (such as IL-8) Data are means Ϯ SD, unless indicated. V O2, oxygen consumption; RER; respiratory exchange rate; SPO2, oxygen saturation measured by pulse oximetry; ⌬SPO2, change in SPO2 from rest to symptom limitation; ⌬IC, change in IC from rest to symptom limitation. *Nonnormally distributed variables reported as median (IQR). and subsequent neutrophil recruitment into the airways. Increased sputum IL-8 levels have been correlated with increased sputum cell counts (total, neutrophil, eosinophil, and lymphocyte) during a COPD exacerbation, while increased levels of sputum IL-6 have correlated with total, eosinophil, and lymphocyte sputum cell counts (5). We found a reduction in sputum IL-8 and IL-6 in our patients following incremental exercise, again suggesting that an acute bout of incremental Fig. 1 . Effect of an incremental exercise test to symptom limitation on sputum cytokines in steroid-naïve patients with chronic obstructive pulmonary disease (COPD). Numerical data over the 3 collection time points (baseline, 2 h post, and 24 h post) is represented as box-and-whisker diagrams for each sputum cytokine. The edge of box closest to zero represents 25th percentile while other edge represents 75th percentile. Line inside box represents the median score, while the ends of the whiskers represent 10th and 90th percentile. There was a reduction in IL-6 24 h following exercise (A) compared with baseline (P ϭ 0.01). IL-8 (B) and chemokine (C-C motif) ligand 5 (CCL5; D) were decreased 2 h and 24 h following exercise (P ϭ 0.0098 and P ϭ 0.0012, respectively). There was no significant change in IL-10 (C; P ϭ 0.069). P values were derived using the Friedman test. exercise results in a different inflammatory response than a COPD exacerbation. The reduction in sputum IL-6 and IL-8 levels following incremental exercise may result in a "relative" inhibition of neutrophil recruitment into the airways, offering some degree of airway protection.
Immediately postexercise there was an increase in hemoglobin and hematocrit, which returned to baseline within 2 h. This finding has commonly been reported in healthy individuals following incremental exercise (30, 53) . With the use of recognized plasma volume calculations (14, 25) , the reduction in plasma volume was Ͻ1% 2 h after exercise. As such, we are confident that changes in blood volume have not influenced our results. We observed an increase in serum total white blood cell count, neutrophils, lymphocytes, and monocytes immediately following incremental exercise. These results are similar to the findings of van Helvoort et al. (62) , who observed increases in blood neutrophils, lymphocytes, and monocytes after a similar bout of exercise in COPD patients and control subjects. The same author also reported an increase in systemic IL-6 after an incremental exercise test and 6-min walk test in patients with COPD (60), whereas we found no significant change in serum IL-6. The contrasting results may be explained by different COPD populations as our subjects had less severe airflow obstruction, no significant muscle wasting, and minimal oxygen desaturation during exercise. CD4 ϩ and CD8 ϩ T lymphocytes are important components of the airway inflammation seen in COPD patients. CD8
ϩ T lymphocytes have been implicated in the pathogenesis and progression of COPD (3) and are commonly increased during COPD exacerbations (36) . In COPD patients, CD8
ϩ T lymphocytes have been shown to mediate lung parenchymal destruction through the effects of specific cytokines (21, 34) and by the secretion of cytotoxic mediators (28) . Elevated numbers of CD4 ϩ T lymphocytes have been found within emphysematous lungs (35) and help activate and promote long-term survival of CD8ϩ T lymphocytes. In our study, the CD4 ϩ / CD8 ϩ T-lymphocyte ratio in the blood decreased immediately following incremental exercise with return to baseline levels 2 h later. This was primarily a result of an increase in CD8 ϩ T lymphocytes immediately after incremental exercise. These findings are similar to Bruunsgaard et al. (8) , who found an increase in blood CD8 ϩ T lymphocytes 20 and 30 min after exercise in healthy subjects with return to baseline levels 2 h following exercise (8) . Interestingly, CD8
ϩ T lymphocytes are known to secrete CCL5 (57, 63) . The relative systemic increase in CCL5 following incremental exercise may have, in part, been related to the transient increase in CD8 ϩ T lymphocytes immediately after incremental exercise. CD8 ϩ T lymphocytes have previously been shown to be increased in induced sputum of patients with COPD (58) . We attempted to assess changes in sputum levels of CD4 ϩ and CD8 ϩ T lymphocytes but were only able to obtain data in less than half of all samples. Therefore, it is unclear whether the transient rise in blood CD8 ϩ T lymphocytes was associated with increased levels in the airways of our patients. This is the first study to examine the anti-inflammatory response to an acute bout of incremental exercise in patients with COPD. We observed no significant change in sputum or serum IL-10 levels. However, given the reduction in sputum proinflammatory cytokines and serum CCL5, this may represent an improvement in the proinflammatory:anti-inflammatory balance. In healthy individuals following an acute bout of aerobic exercise, the proinflammatory response is balanced by an anti-inflammatory response (42, 56) , which is thought to be mediated by proinflammatory cytokines/myokines (45, 46) . It is unclear whether the lack of an increase in IL-10 in our subjects was due to a blunted IL-10 response or lack of a significant proinflammatory response. We found a reduction in proinflammatory sputum cytokines and no significant changes in serum IL-6, IL-8, and hsCRP following incremental exercise. Given that IL-6 has been shown to be elevated postexercise in healthy individuals (45) , it is feasible that the incremental exercise performed in this study was not of a large enough stimulus to cause a sufficient proinflammatory response to stimulate IL-10 production in our study subjects.
There are several limitations of this study. First, repeated induced sputum tests within 24 -48 h have been found to cause a change in sputum cell counts (40, 59) . However, the number of eosinophils was not significantly different between baseline and 24 h (59). Second, there was no previous literature measuring airway inflammation after incremental exercise in COPD patients. We chose induced sputum collection 2 h after exercise, based on the finding of increased sputum neutrophilia 2 h postexercise in healthy subjects with exercise-induced bronchoconstriction (19) . Third, the study was not designed to evaluate the mechanisms that caused the documented changes.
Conclusion
This is the first study examining both airway and systemic inflammatory changes in patients with COPD following an acute bout of incremental exercise. The increase in sputum eosinophils following exercise was mirrored by a decrease in blood eosinophils, suggesting recruitment from the blood into the airways. The observed changes in serum CCL5 appears to mediate this eosinophil recruitment. Reduction in sputum proinflammatory cytokines (IL-6, IL-8, and CCL5) may indicate a protective effect of exercise in COPD patients. Further studies are now needed to better understand the immunological and inflammatory responses to both acute and chronic exercise to help determine how exercise affects airway and systemic inflammation in patients with COPD. 
